Diabetes 文獻一篇

bjouxz

Diabetes. 2016 Jan;65(1):269-75. doi: 10.2337/db15-0893. Epub 2015 Oct 15.
& S; l9 |6 o& ~9 Y9 u& vThe Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
8 ?# Z0 i6 l8 @Thazhath SS1, Marathe CS1, Wu T1, Chang J1, Khoo J1, Kuo P2, Checklin HL1, Bound MJ1, Rigda RS1, Crouch B3, Jones KL1, Horowitz M1, Rayner CK4
/ _, E( ^1 `9 |5 N% [3 A( _1 M0 D: u: L. H; V
Link: http://diabetes.diabetesjournals.org/content/65/1/269.long
7 J1 }# B- E* O% ]
$ E; J5 ]6 M- b  U+ GThanks so much!

farui

The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial  H9 D( r4 o& W% g